Asthma in the elderly;L'asthme du sujet âgé

Revue des Maladies Respiratoires

Volumn 20, Issue 1 I, 2003, Pages 95-103

  Radenne, F ^b   Verkindre, C ^b   Tonnel, A B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Allergen avoidance; Asthma; Beta 2 adrenergics; Elderly; Inhaled corticosteroids; Intrinsic Asthma

Indexed keywords

ACETYLSALICYLIC ACID; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE; FORMOTEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SALMETEROL; THEOPHYLLINE;

AGED; AGING; ALLERGY; ASTHMA; CARDIOTOXICITY; CIGARETTE SMOKING; COMORBIDITY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DOSE RESPONSE; FEMALE; GASTROESOPHAGEAL REFLUX; GERIATRIC PATIENT; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW; SIDE EFFECT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGE FACTORS; AGED; ALLERGENS; ARRHYTHMIA; ASTHMA; BRONCHODILATOR AGENTS; CHOLINERGIC ANTAGONISTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRACTURES, BONE; HUMANS; INCIDENCE; LEUKOTRIENE ANTAGONISTS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RECEPTORS, ADRENERGIC, BETA-2; RESPIRATORY FUNCTION TESTS; RISK FACTORS; THEOPHYLLINE; TIME FACTORS;

EID: 0242432372     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Broder I, Barlow PP, Horton RJM: The epidemiology of asthma and hay fever in a total community, Tecumseh, Michigan. II. The relationship between asthma and hay fever. J Allergy 1962; 33: 524-31.
2. Yunginger JW, Reed CE, O'Connell EJ, Melton LJ, O'Fallon WM, Silverstein MD: A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis 1992; 146: 888-94.
3. Burr ML, Charles TJ, Roy K, Seaton A: Asthma in the elderly: an epidemiological survey. Br Med J 1979; 1: 1041-4.
4. Dodge RR, Burrows B: The prevalence and incidence of asthma and asthma-like symptoms in a general population sample. Am Rev Respir Dis 1980; 122: 567-75.
5. Bauer BA, Reed CE, Yunginger JW, Wollan PC, Silverstein MD: Incidence and outcomes of asthma in the elderly. Chest 1997; 11: 303-10.
6. Silverstein M, Reed C, O'Connell E, Melton III JL, O'Fallon WM, Yunginger JW: Long-term survival of a cohort of community residents with asthma. N Engl J Med 1994; 331: 1537-41.
7. Barger LW, Vollmer W, Felt RW: Further investigations into the recent increase in asthma death rates: a review of 41 asthma deaths in Oregon in 1982. Ann Allergy 1988; 60: 31-6.
8. Weiss KB, Wagener DK: Changing patterns of asthma mortality. Identifying target of asthma mortality. JAMA 1990; 263: 2223-8.
9. Marquette CH, Saulnier F, Leroy O, Wallaert B, Chopin C, Demarcq JM, Durocher A, Tonnel AB: Long-term prognosis of near-fatal asthma: a 6 year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 1992; 146: 76-1.
10. National Heart, Lung and Blood Institute. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHL-BI/WHO workshop report. National Institutes of Health, Bethesda. 1995. National Heart and Blood Institute publication number 95-3659.
11. Braman SS, Kaemmerlen JT, Davis SM: Asthma in the elderly; a comparison between patients with recently acquired and long standing disease. Am Rev Respir Dis 1991; 143: 336-40.
12. Connoly MJ, Crowley JJ, Charan NB, Nielson CP, Vestal RE: Impaired bronchodilator response to Albuterol in healthy elderly men and women. Chest 1995; 108: 401-6.
13. Pfeifer MA, Weinberg CR, Cook D, Best JD, Reenan A, Halter JB: Differential changes of autonomic nervous system function with age in man. Am J Med 1983; 75: 249-58.
14. Sparrow D, O'Connor GT, Rosner B, Segal MR, Weiss ST: The influence of age and level of pulmonary function on nonspecific airway responsiveness: the normative aging study. Am Rev Respir Dis 1991; 143: 978-82.
15. Hopp RJ, Bewtra A, Nair NM, Townley RG: The effect of age on metacholine response. J Allergy Clin Immunol 1985; 76: 609-13.
16. Renwick DS, Connolly MJ: The relationship between age and bronchial responsiveness. Evidence from a population survey. Chest 1999; 115: 660-5.
17. Woodruff PG, Khashayar R, Lazarus SC, Janson S, Avila P, Boushey HA, Segal M, Fahy JV: Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2000; 108: 753-8.
18. Arbee RA, Lebowitz MD, Thompson HC, Burrows B: Immediate skin-test reactivity in a general population sample. Ann Intern Med 1976; 84: 129-33.
19. Ford RM: Aetiology of asthma: a review of 1,551 cases. Med J Aust 1969; 1: 628-31.
20. Cassino C, Berger KI, Goldring RM, Norman RG, Kaemmerman S, Ciotoli C, Reibman J: Duration of asthma and physiologic outcomes in elderly non smokers. Am J Respir Crit Care Med 2000; 162: 1423-8.
21. Huss K, Naumann PL, Mason PJ, Nanda JP, Huss RW, Smith CM, Hamilton RG: Asthma severity, atopic status, allergen exposure and quality of life in elderly persons. Ann Allergy Asthma Immunol 2001; 86: 524-30.
22. Slavin RG: Asthma in the elderly: do they need an allergy evaluation? Ann Allergy Asthma Immunol 2001; 86: 492-3.
23. Rackeman F: A working classification of asthma. Am J Med 1947; 3: 601-6.
24. Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB: The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20: 528-33.
25. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Associfi B, Pfister R, Menz G, Robinson DS, Kay AB, Corrigan CJ: IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and non atopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154: 1497-504.
26. Ying S, Meng Q, Zeibecoglou K, Mac Farlane AJ, Robinson DS, Humbertm, Kay AB: Eosinophil chemotactic chemokines (eotaxin 1, eotaxin2, RANTES, MCP-3, MCP-4) and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and non-atopic (intrinsic) asthmatics. J Immunol 1999; 163: 6321-9.
27. Zeibecoglou K, Ying S, Meng Q, Poulter L, Robinson DS, Kay AB: The expression of IL-10 and IL-12 in induced sputum of atopic, non atopic asthmatics atopic and normal control subjects. J Allergy Clin Immunol 2000; 106: 697-704.
28. Petheram I, Jones DA, Collins JV: Assessment and management of acute asthma in the elderly: a comparison with younger asthmatics. Postgrad Med J 1982; 58: 149-55.
29. Connolly MJ, Crowley JJ, Charan NB, Nelson CP, Vestal RE: Reduced subjective awareness of broncho-constriction provoked by metacholine in elderly asthmatics and normal subjects as measured on a simple awareness scale. Thorax 1992; 47: 410-3.
30. Dyer CA, Hill SL, Stockley RA, Sinclair AJ: Quality of life in elderly subjects with a diagnostic label of asthma from a general practice registers. Eur Respir J 1999; 14: 39-44.
31. Nejjari C, Tessier JF, Barberger-Gateau P, Jacqmin H, Dartigues JF, Salamon R: Functional status of elderly people treated for asthma-related symptoms: a population based case-control study. Eur Respir J 1994; 7: 1077-83.
32. Enright PL, Mcclelland RL, Newman AB, Gottlieb DJ, Lebowitz MD, for the cardiovascular Health Study Research Group: underdiagnosis and undertreatment of asthma in the elderly. Chest 1999; 116: 603-13.
33. Peat JK, Woolcock AJ, Cullen K: Rate of decline of lung function in subjects with asthma. Eur Respir J Dis 1987; 70: 171-9.
34. Brown PJ, Greville HW, Finucane KE: Asthma and irreversible airflow obstruction. Thorax 1984; 39: 131-6.
35. Lange PJ, Parner J, Vestbo J, Schnohr P, Jensen G: A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
36. Van Schayck CP, Dompeling E, Van Herwaarden CLA, Wever AM, Vanweel C: Interacting effects of atopy and bronchial hyperresponsiveness on the annual decline in lung function and the exacerbation rate in asthma. Am Rev Respir Dis 1991; 144: 1297-301.
37. Sherman CB, Kern D, Richardon ER, Hubert M, Fogel BS: Cognitive function and spirometry performance in the elderly. Am Rev Respir Dis 1993; 148: 123-6.
38. Braman SS: Asthma in the elderly. Clin Chest Med 1993; 14: 413-22.
39. Cabanes L, Costes F, Weber S, Regnard J, Benvenuti C, Castaigne A, Guerin F, Lockhart A: Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. N Engl J Med 1992; 326: 1661-5.
40. Cabanes L: Bronchial hyperreactivity and heart failure. Rev Prat 1992; 42: 329-34.
41. Raiha I, Hietanen E, Sourander L: Symptoms of gastro-oesophageal disease in elderly people. Age Ageing 1991; 20: 365.
42. Sluiter HJ, Köeter GH, De Monchy JGR, Postma DS, De Vries K, Orie NGM: The Dutch Hypothesis (chronic non-specific lung disease) revisited. Eur Respir J 1991; 4: 479-89.
43. National Asthma Education and Prevention Programm. Expert panel report 2: Guidelines for the diagnosis and management of Asthma. Bethesda Md: National Heart and Blood Institute. 1997; (N.I.Y. publication n° 97-4041).
44. Sin DD, Tu JV: Underuse of inhaled steroid therapy in elderly patients with asthma. Chest 2001; 119: 720-5.
45. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, Lahive K, Leboff MS: Effects of inhaled glucocorticoïdes on bone density in premenopausal women. N Engl J Med 2001; 345: 941-7.
46. Wong CA, Walsh LJ, Smith CJP, Wisniewski AF, Lewis SA, Hubbard R, Cawte S, Green DJ, Pringle M, Tattersfield AE: Inhaled corticosteroid use and bone mineral density in patients with asthma. Lancet 2000; 355: 1399-403.
47. Lipworth BJ: Systemic effects of inhaled corticosteroid therapy: a systematic review and metaanalysis. Arch Intern Med. 1999; 159: 941-55.
48. Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, Mcnutt M, Buist AS, Rebuck AS: The use of β agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326: 560-1.
49. Robin ED, McCauley R: Sudden cardiac death in bronchial asthma and inhaled beta-adrenergic agonists. Chest 1992; 101: 1699-702.
50. Vestal RE, Wood AJJ, Shand DG: Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther 1979; 26: 181-6.
51. Schannon M, Lovejoy FH: The influence of age vs peak serum concentration on life threatening events after chronic theophylline intoxication. Arch Intern Med 1990; 150: 2045-55.
52. Korenblat PE for the antileucotriene Working Group. The role of antileucotrienes in the treatment of asthma. Ann Allergy Asthma Immunol 2001; 86: 31-9.
53. Dahlen B, Nizankowka E, Szczeklik A, Zetterstrom O, Bochenek G, Kumlin M, Mastalerz L, Pinis G, Swanson LJ, Boodhoo TI, Wright S, Dube LM, Dahlen SE: Benefits from adding the 5-lipooxygenase inhibitor Zileuton to conventional therapy in aspirin intolerant asthmatics. Am J Respir Crit Care Med 1998; 157: 1187-204.
54. Leff JA, Israel E, Noonan NJ: montelukast allows tapering of inhaled corticosteroids in asthmatic patients whilst maintaining clinical stability. Am J Respir Crit Care Med 1997; 155: A976.